Adam, Saiden B.

HRN: 08-93-88  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2025
CEFUROXIME 750MG (VIAL)
11/14/2025
11/21/2025
IV
750mg
Q8hours
Urinary Tract Infection
Checking Initial Appropriateness 
11/18/2025
CEFTRIAXONE 1G (VIAL)
11/18/2025
11/25/2025
IV
1.4 Grams
Q12h
UTI
Checking Final Appropriateness 
11/23/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/23/2025
11/30/2025
IV
1.5g
Q6H
Intraabdominal Infection
Checking Initial Appropriateness 
11/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/23/2025
11/30/2025
IV
290mg
Q8H
Intraabdominal Infection
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: